Ibudilast Appears to Slow Brain Atrophy Progression in MS
FRIDAY, Aug. 31, 2018 — In patients with progressive multiple sclerosis, slower progression of brain atrophy was seen with ibudilast
Read more
New nusinersen drug delivery method identified for spinal muscular atrophy patients
STRASBURG, PA- A new report has identified an alternative method to deliver nusinersen to patients with spinal muscular atrophy (SMA)
Read more